The purpose of this study is to investigate the effect of travelling to moderate altitude and of nocturnal oxygen therapy during a stay at moderate altitude on breathing and sleep of patients with pulmonary hypertension or with interstitial lung disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean nocturnal oxygen saturation measured by pulse oximetry
Timeframe: Approximately 8 hours (during the first night at 2048 m)
Apnea/hypopnea index measured by polysomnography
Timeframe: Approximately 8 hours (during the first night at 2048 m)